575 related articles for article (PubMed ID: 2893634)
1. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
McCaffrey PM; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
[TBL] [Abstract][Full Text] [Related]
2. Studies of the agonist and antagonist activity of cicloprolol in man.
McCaffrey PM; Burke M; Riddell JG; Shanks RG
Eur J Clin Pharmacol; 1988; 34(6):569-75. PubMed ID: 3169110
[TBL] [Abstract][Full Text] [Related]
3. The selectivity of xamoterol, prenalterol, and salbutamol as assessed by their effects in the presence and absence of ICI 118,551.
McCaffrey PM; Riddell JG; Shanks RG
J Cardiovasc Pharmacol; 1988 May; 11(5):543-51. PubMed ID: 2455840
[TBL] [Abstract][Full Text] [Related]
4. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods.
Silke B; Hanratty CG; Riddell JG
J Cardiovasc Pharmacol; 1999 Jun; 33(6):859-67. PubMed ID: 10367588
[TBL] [Abstract][Full Text] [Related]
5. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effect on heart rate variability of some agents acting at the beta-adrenoceptor using nonlinear scatterplot and sequence methods.
Silke B; Riddell JG
Cardiovasc Drugs Ther; 1998 Oct; 12(5):439-48. PubMed ID: 9926274
[TBL] [Abstract][Full Text] [Related]
7. Selectivity of xamoterol, prenalterol and salbutamol as assessed by their effects in the presence and absence of ICI 118 551.
McCaffrey PM; Riddell JG; Shanks RG
Eur Heart J; 1990 Apr; 11 Suppl A():54-5. PubMed ID: 1971592
[TBL] [Abstract][Full Text] [Related]
8. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
O'Connor PC; Finch MJ; Harron DW; Meredith PA; McDevitt DG; Shanks RG
Br J Clin Pharmacol; 1985 Dec; 20(6):659-67. PubMed ID: 2868744
[TBL] [Abstract][Full Text] [Related]
11. Effects of beta-adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.
Reid W; Ewing DJ; Harry JD; Smith HJ; Neilson JM; Clarke BF
Br J Clin Pharmacol; 1987 Apr; 23(4):383-9. PubMed ID: 2883987
[TBL] [Abstract][Full Text] [Related]
12. Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors.
Malinowska B; Schlicker E
Br J Pharmacol; 1996 Mar; 117(5):943-9. PubMed ID: 8851515
[TBL] [Abstract][Full Text] [Related]
13. Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone.
Grove A; McFarlane LC; Lipworth BJ
Thorax; 1995 Feb; 50(2):134-8. PubMed ID: 7701450
[TBL] [Abstract][Full Text] [Related]
14. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
Fitzgerald DE; Harry JD
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the beta-adrenoreceptors which mediate the isoprenaline-induced changes in finger tremor and cardiovascular function in man.
Pringle TH; Riddell JG; Shanks RG
Eur J Clin Pharmacol; 1988; 35(5):507-14. PubMed ID: 2853055
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
Tomlinson B; Cronin CJ; Graham BR; Prichard BN
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
[TBL] [Abstract][Full Text] [Related]
17. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
[TBL] [Abstract][Full Text] [Related]
18. Assessment of beta-adrenoceptor antagonists in asthmatic patients.
Ruffin RE; McIntyre EL; Latimer KM; Ward HE; Crockett AJ; Alpers JH
Br J Clin Pharmacol; 1982; 13(Suppl 2):325S-335S. PubMed ID: 6125185
[TBL] [Abstract][Full Text] [Related]
19. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
Riddell JG; Shanks RG
Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
[TBL] [Abstract][Full Text] [Related]
20. Beta-adrenoceptor modulation and heart rate variability--the value of scatterplot measures of compactness.
Silke B; Hanratty CG; Veres SM; Riddell JG
Cardiovasc Drugs Ther; 2000 Aug; 14(4):433-40. PubMed ID: 10999651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
